Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000772
Status:
COMPLETED
Last Update Posted:
2021-10-28
First Post:
1999-11-02
Brief Title:
A Phase I Open-Label Study of the Safety Tolerance and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
Sponsor:
Organization:
National Institute of Allergy and Infectious Diseases NIAID